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is the targeting of membranes pose problems for therapeutic use in that they will exert a detergent-like effect, compromising both microbial and mammalian cell membranes due to antimicrobial and cytotoxic effects [7]. In the host, these effects can range from irritation at the site of exposure to severe vascular injuries and life-threatening events such as seizures or cardiac arrhythmias [5] when antiseptics are used clinically as a skin disinfectant, as a lavage for infected wounds, and within antimicrobial catheters [8]. Cationic antimicrobial peptides have been shown to exert their antimicrobial effect by selective permeabilization of predominantly negatively charged bacterial membranes [9]. However, just like antimicrobial action, cytotoxicity may be produced by a multitude of mechanisms. The treatment of cells at toxic concentrations can result in loss of membrane integrity and cell lysis, with resulting leakage of cytoplasmic cell contents, in a process termed necrosis. Alternatively the compound may invoke genetically programmed cell death, called apoptosis, where cells stop actively dividing and therefore growing [10]. 
Apoptotic markers are well defined and include changes in the refractive index of the cell, destruction of the nucleus with cleavage of DNA into fragments and shrinkage of the cytoplasm [11]. These markers are not present in necrosis as membrane destruction is rapid, with limited time for activation of apoptotic mediators. Cells undergoing apoptosis will eventually undergo secondary necrosis as metabolic pathways shut down, with loss of membrane integrity resulting in cell lysis [12]. The differentiation of microbial and human cells is important for antimicrobials, in order to achieve resolution of infection while also limiting antimicrobial-related damage. However, in the development of new antimicrobials, there is a reduced likelihood that animal and human toxicity will halt the developmental process. This is shown by a survey of seven British pharmaceutical companies between 1964 and 1985 in which only eleven (10%) of new antimicrobials tested were halted due to a problem with toxicity 
profiles compared with seventeen (16%) of other drug groups 
[13-15]. Poor antimicrobial and pharmacokinetic efficacy were deemed more problematic. Despite the reduced likelihood of an antimicrobial being halted at the developmental stage due to toxicity factors, withdrawals have occurred after clinical approval, with resulting patient morbidity, death and loss of revenue. For 
example, temafloxacin was approved for use as an antibiotic in 1992 but six months after its approval it was withdrawn from the market because of toxicity associated with haemolytic anaemia, 
AbstractFluorescence microscopy serves as a valuable tool for assessing the structural integrity and viability of eukaryotic cells. Through the use of calcein AM and the DNA stain 4,6-diamidino-2-phenylindole (DAPI), 
cell viability and membrane integrity can be qualified. Our group has previously shown the ultra-short cationic antimicrobial peptide 
H-OOWW-NH2; the amphibian derived 27-mer peptide Maximin-4and the ultra-short lipopeptide C12-OOWW-NH2 to be effective 
against a range of bacterial biofilms [1], displaying potential for use in the prevention of medical device-related infections [2]. Analysis of 
fluorescence micrographs, after staining with calcein AM and DAPI, shows the likely mode of cytotoxic action of cationic antimicrobial peptides and lipopeptides are via direct membrane disruption in eukaryotic cells. Selectivity is towards cidal action against prokaryotic cells, whose membranes are anionic in composition, such as those of bacteria, rather than for neutral zwitterionic membranes of eukaryotic cells. Membrane selectivity is determined by a multitude of physical parameters, particularly charge and hydrophobicity. The charge of the antimicrobial determines the extent of the initial electrostatic interactions with both prokaryotic and eukaryotic membranes, with a larger cationic charge favoring antimicrobial action. Tailoring of these properties is likely to be the key in successfully transferring antimicrobial peptides from laboratory experiments into clinical practice as safe pharmaceutical formulations.
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Introduction
The cytotoxic: therapeutic balance in antimicrobialsCytotoxicity relates to the ability of a compound to exert a 
toxic effect on cells, or more specifically on human cells. No drug is completely free from toxicity, with associated adverse drug reactions generally the most common reason for withdrawal of approved drugs [3,4]. There instead exists a balance between the need for treatment and the level of toxicity produced at therapeutic levels. As a class of drugs, antimicrobials are particularly troublesome with regard to cytotoxicity, as their 
significant role is to ultimately achieve microbial cell death [5]. 
For example, some antimicrobial peptides may provide benefit at lower antimicrobially active concentrations with regard to prevention of infected wounds; however, at higher concentrations they may exhibit cytotoxicity that might adversely affect wound healing [6]. Antiseptic agents whose main mechanism of action 
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clotting disorders and liver and kidney impairment [16]. 
Therefore cytotoxic profiling is a necessity for the future design of antimicrobials. Ultrashort antimicrobial peptides, lipopeptides and the amphibian peptide Maximin-4 have previously been 
shown by our group to display antimicrobial activity in the µg/mL range against a range of important nosocomial pathogens [1]. 
To evaluate their potential use as anti-biofilm agents for medical 
device applications, it is necessary to formulate toxicity profiles 
to assess their relative action against the cells of eukaryotic/
mammalian/human hosts. The standard antimicrobials rifampicin and vancomycin are used as comparators.
Methods
Chemicals and reagentsPhosphate buffer saline (PBS) tablets, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), DAPI, calcein AM, vancomycin (as hydrochloride hydrate) and rifampicin were obtained from Sigma-Aldrich (Dorset, UK). Methanol, 
ethanol and dimethyl sulphoxide (DMSO) analytical reagent 
grade were obtained from Fisher Scientific (Leicestershire, 
UK). Dulbecco’s modified Eagle’s medium (DMEM) 
containing 4500mg/L D-glucose, L-glutamine, trypsin with 
ethylenediaminetetra-acetic acid (EDTA) and 1% penicillin/
streptomycin obtained from Invitrogen (Paisley, UK). 5% v/v 
foetal bovine serum was obtained from Biosera (East Sussex, UK). Rink amide 4-(2’,4’-dimethoxyphenyl-Fmoc-aminomethyl)-
phenoxyacetamido-MHBA (MBHA) resin, all 9-fluorenylmethoxy carbonyl (Fmoc) L-amino acids and 2-(1H-benzotriazole-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were obtained from Merck Chemicals Ltd. (Nottingham, UK). Dodecanoic (lauric) acid was obtained from Sigma-Aldrich 
(Dorset, UK). All other reagents/solvents were peptide synthesis grade.
Peptide synthesis Peptides were synthesized using standard 
9-fluorenylmethoxy carbonyl (Fmoc) solid phase protocols on 
Rink Amide MHBA resin, using a CEM Liberty (Buckingham, UK) microwave enhanced automated peptide synthesizer. Peptide elongation was effected using standard HBTU coupling chemistry in dimethylformamide (DMF) solvent with four-fold molar excess 
of diisopropylethylamine (DIEA) in N-methyl-2-pyrrolidone (NMP) and a three-fold molar excess of each Fmoc-protected amino acid or free fatty acid. Fatty acids were coupled using standard (microwave enhanced) amino acid coupling conditions 
(18 W, 75°C, 300 s) employed for all syntheses. All peptides 
were cleaved from the resin using 95% trifluoroacetic acid, 2.5% triisopropylsilane and 2.5% thioanisole (2 h, room temperature), following standard work-up (crude product was dissolved in ethyl acetate and subjected to a series of washes with 1mM HCl (3 
x 50 ml) and water (3 x 50 ml) and dried over anhydrous MgSO4. 
The identity of each lipopeptide was confirmed by electrospray mass spectroscopy (Thermo Finnigan LCQ Deca ion trap). Peptide purity was analyzed by RP-HPLC using a Gemini C18, 250 mm x 4.6 mm column (Phenomonex, UK), a 2-60% acetonitrile 
gradient [30min] in 0.05% TFA-water at a flow rate of 1 mL/min. 
All peptides/lipopeptides were found to have >90% purity.
Qualitative cell survival analysis: fluorescence 
microscopy
HaCaT keratinocyte cell line (Cell Line Services, Eppelheim, 
Germany, collection number: 400693) were cultured in DMEM 
containing 4500 mg/L D-glucose from Invitrogen (Paisley, UK), supplemented with 2 mM L-glutamine foetal bovine serum and 
1% penicillin/streptomycin. Cells were grown at 37°C and 5% CO2 
and subcultured at 80–90% confluency. Subculturing consisted of removal of spent medium, rinsing of the adherent cell surface 
with PBS before treatment with trypsin-EDTA for cell monolayer detachment. Cell viability and morphology were assessed by 
fluorescence microscopy. HaCaT cells were cultured (until at least a third passage) and inoculated into sterile polystyrene 
Nunc™ 96-well tissue culture treated microtitre plates (VWR International Ltd, Leicestershire, UK) at a concentration of 1 x 104 cells/well and incubated at 37°C and 5% CO2 for 24 ± 1hour, 
until approximately 90% confluency as described above. After this time, the medium was removed and replaced with fresh growth medium, as described above, but containing a range of 
concentrations (1000 to 3.91 µg/ml) of individually prepared 
vancomycin, rifampicin, Maximin-4, H-OOWW-NH2 and C12-
OOWW-NH2 for 1 hour. 90% ethanol only controls were also tested as a positive control for total kill, as evidenced by of the method of Mossman (Mosmann, 1983) and a negative control, containing only medium, was also tested. After 1 hour of exposure 
at 37°C and 5% CO2, medium was removed and cells washed with PBS in order to remove residual compounds under study. Cells 
were exposed concurrently to 100 μl PBS at 37°C containing 300 
nM DAPI and 5 μM calcein AM. Cells were incubated at 37°C and 
5% CO2 for 30 minutes before being washed five times with PBS. 
Cells were then analysed by fluorescent microscopy using filters corresponding to the manufacturers recommended excitation wavelength of both DAPI (350nm) and calcein AM (494nm). Cell 
images were also taken at 555 nm to aid in the assessment of cell/cell membrane integrity. Six replicates were produced for each concentration of antimicrobial to ensure accurate qualitative data was obtained.
Results and DiscussionThrough the use of a variety of assays, the mode of cellular destruction by a given cytotoxic compound can be determined. The use of cell based assays has increased steadily over recent years and there is now a trend for pharmaceutical companies to revert to high throughput chemical cytotoxicity assays that utilise cells in correlation with, or in preference to, animal testing 
[17]. Specific data obtained for each method show high degrees of correlation [18]. In the literature there is an increasing emphasis on the utilisation of haemolysis and MTT assays for antimicrobial 
peptides [1]. The use of fluorescence microscopy can serve as a useful qualitative tool alongside these methods.In order to qualitatively evaluate the potential of the 
synthesised ultrashort cationic antimicrobial peptide H-OOWW-NH2, Maximin-4 and the ultrashort lipopeptide C12-OOWW-NH2to 
cause cellular toxicity, fluorescence microscopy was utilized. 
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As with the majority of antimicrobials, interaction with the cell membrane of microorganisms is fundamental to the mode 
of action of cationic antimicrobial peptides. The significant difference in the compositions of eukaryotic membranes in comparison to prokaryotic membranes highlights the important selectivity of these compounds for microbial cells. Cationic antimicrobial peptides will therefore bind preferentially to the negatively charged phospholipid bilayer of bacterial cells [9]. This is advantageous with regard to reducing toxicity in any potential therapeutic environment. The membrane lytic properties induced by the cationic 
antimicrobial peptides are confirmed through the use of 
fluorescence micrographs after staining of exposed HaCaT cell lines with DAPI and calcein AM. The most antimicrobially potent peptides studied in our previous work [1,2] were selected (Maximin-4 and C12-OOWW-NH2) with vancomycin, rifampicin 
and H-OOWW-NH2 acting as comparative controls and 90% ethanol as a positive control. Interpretation of these results was based upon the binding of DAPI to DNA-double strands of HaCaT 
cell lines, yielding a fluorescent blue complex at wavelength 350 nm [19]. DAPI has been shown to be useful for the detection of nonviable cells with compromised membranes in live cell cultures [20]. It is only when the membrane integrity is compromised that DAPI can enter the cell cytoplasm and pass into the nucleus to stain DNA [21]. Cell viability is determined through the use of 
calcein AM. Calcein AM is a non-fluorescent lipid-soluble complex that can passively cross intact cell membranes in an electrically 
neutral form to be converted to the intensely fluorescent calcein [22]. This conversion occurs within the cell cytoplasm by live cells that possess active intracellular esterases (Figure 1). Calcein’s hydrophilic and polyanionic character allows it to be retained 
within living cells. An intense fluorescent green calcein complex visible at 494 nm was indicative of the presence of viable cells, 
with the absence of a blue fluorescent DAPI stain at 350 nm also showing an intact cell membrane as demonstrated by the negative control present in Table 1 [23].
A range of fluorescent micrographs are shown from Table 1 to 6 at both cytotoxic and non-cytotoxic concentrations of 
antimicrobials. H-OOWW-NH2 has a reduced cytotoxic profile 
shown by the presence of green fluorescent calcein even at 
concentrations as high as 1000 µg/ml. The blue fluorescent DAPI stain is present at similar concentrations, proving membrane disruption does occur but to a lesser extent than the positive 
90% ethanol control or 1000 µg/ml of C12-OOWW-NH2. The peptides were only exposed to the HaCaT cell lines for 1 hour as membrane permeabilization was predicted to be a rapid process. 
As previously shown by our group, significant cell death occurs with peptides such as C12-OOWW-NH2 after 24 hour exposure at 
cytotoxic concentrations (>62.5 µg/ml) [1]. This study shows that cell death occurs within 1 hour exposure at the highest 
Figure 1: The conversion of hydrophobic calcein AM to the hydrophilic and fluorescent complex calcein by endogenous intracellular enzymes present in viable HaCaT cells.
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Control Cell Image (555 nm)
4,6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) Excitation 
Wavelength (350 nm) Presence of 
Blue =  DAPI release from cells, cell 
membrane compromised
Calcein AM Excitation Wavelength 
(494 nm).  Presence of green = 
Calcein AM retained by cells, cells 
viable.
Total Kill (90% ethanol)
Zero Kill (PBS)
Table 1: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells after 1 hour exposure to 90% ethanol (positive control) and medium (negative control).
Concentration of 
H-OOWW-NH2
(µg/ml)
Cell Image (555 nm) 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Excitation Wavelength (350 nm) Presence of Blue =  DAPI release from cells, cell membrane compromised
Calcein AM Excitation Wavelength (494 nm).  Presence of green = Calcein AM retained by cells, cells viable.
1000
62.5
Table 2: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells after 1 hour exposure to H-OOWW-NH2.
concentration tested (1000 µg/ml). Cell death via is confirmed 
by fluorescent micrographs. At cytotoxic concentrations of 1000 
µg/ml, the peptides Maximin-4 (Table 4) and C12-OOWW-NH2 (Table 3) produce normal large and intact nuclear structures (shown by DAPI counterstain) due to membrane lysis, rather than bright clustered bodies which are a typical feature of chromatin condensation and cellular apoptosis relative to controls (Table 1) [24]. For C12-OOWW-NH2 (Table 3) and Maximin-4 (Table 4) cytotoxicity and cellular necrosis of HaCaT 
cells after 1 hour is minimal at 15 µg/ml. This concentration 
corresponds to approximately the Minimum Biofilm Eradication 
Concentration (MBEC) for C12-OOWW-NH2 and Maximin-4 (both 
15.63 µg/ml) against Staphylococcus epidermidis (ATCC 35984) and Staphylococcus aureus (ATCC 29213) respectively [1,2]. 
Although these MBEC values are obtained after 24 hour exposure 
to these peptides, whereas fluorescence results are observed 
after 1 hour, biofilm eradication kinetics for each peptide after 1 hour show a preference for action against Gram-positive 
bacterial biofilm rather than HaCaT cells. Minimal cytotoxicity was shown for vancomycin at the highest concentration tested 
(1000 µg/ml) (Figure 6). Rifampicin expressed low qualitative 
cytotoxicity at 15 µg/ml but at 1000 µg/ml the presence of DAPI 
Page 5 of 8Citation:  Laverty G, Gilmore B (2014) Cationic Antimicrobial Peptide Cytotoxicity. SOJ Microbiol Infect Dis 2(1): 1-8. DOI: http://
dx.doi.org/10.15226/sojmid.2014.00112
Cationic Antimicrobial Peptide Cytotoxicity Copyright: © 2014 Laverty et al.
Concentration of C12-
OOWW-NH2
(µg/ml)
Cell Image (555 nm) 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Excitation Wavelength (350 nm) Presence of Blue =  DAPI release from cells, cell membrane compromised
Calcein AM Excitation Wavelength (494 nm).  Presence of green = Calcein AM retained by cells, cells viable.
1000
62.5
15
Table 3: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells1 hour exposure to C12-OOWW-NH2.
Table 4: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells after 1 hour exposure to the amphibian-derived peptide Maximin-4.Concentration of Maximin-4
(µg/ml)
Cell Image (555 nm) 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Excitation Wavelength (350 nm) Presence of Blue =  DAPI release from cells, cell membrane compromised
Calcein AM Excitation Wavelength (494 nm).  Presence of green = Calcein AM retained by cells, cells viable.
1000
62.5
15
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Concentration of Vancomycin
(µg/ml)
Cell Image (555 nm) 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Excitation Wavelength (350 nm) Presence of Blue =  DAPI release from cells, cell membrane compromised
Calcein AM Excitation Wavelength (494 nm).  Presence of green = Calcein AM retained by cells, cells viable.
1000
62.5
15
Table 5: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells after 1 hour exposure to vancomycin.
Table 6: Fluorescence micrographs showing DAPI and calcein AM counterstains of HaCaT cells after 1 hour exposure to rifampicin.Concentration of Rifampicin
(µg/ml)
Cell Image (555 nm) 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) Excitation Wavelength (350 nm) Presence of Blue =  DAPI release from cells, cell membrane compromised
Calcein AM Excitation Wavelength (494 nm).  Presence of green = Calcein AM retained by cells, cells viable.
1000
15
(blue fluorescent stain) and lack of calcein (green fluorescent stain) proved cytotoxicity occurred in HaCaT cells within 1 hour exposure to the maximum concentration employed. Further 
analysis of the DAPI stain present at 1000 µg/ml rifampicin in 
Table 6 shows DNA to be relatively undefined compared with the positive (90% ethanol) control (Table 1). The presence of bright clustered bodies typical of chromatin condensation shows rapid cellular apoptosis could potentially be the cytotoxic mechanism 
of action of rifampicin (Table 6) [24]. The cell image (555 nm) at this concentration also shows distinct cell-like structures with intact membranes, showing that disruption of the cell membrane structures has not taken place and cellular apoptosis to be the possible mechanism of cell death. For cationic antimicrobial peptides, there is a correlation between a larger ratio of aromatic residues, especially 
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tryptophan, to cationic residues and a high degree of haemolysis 
and cell cytotoxicity [25,26]. Therefore the higher lipophilic: charge ratio provided by C12-OOWW-NH2 (50% of amino acid residues are tryptophan) shows greater membrane interactions and haemolytic activity of equine erythrocytes than that provided by Maximin-4 (51% hydrophobicity but no tryptophan residues). The grouping of sequentially consecutive positive charges to the termini of naturally occurring antimicrobial peptides such as magainin has been shown to provide a locus to which these 
molecules can adsorb to zwitterionic membranes [27]. Other 
factors such as α-helicity, overall hydrophobicity, amphipathicity, hydrophobic movement and angle subtended by charged residues have also been shown to modulate activity against both microbial (particularly Gram-positive bacteria) and mammalian cells, with higher values of each reducing selectivity [28]. Tailoring selection towards microbial rather than eukaryotic membranes 
is therefore not as simple as reducing the hydrophobic: charge ratio. The potential in vivo activity of antimicrobial peptides may be lost under physiological salt and serum conditions with ionic strength a factor in both mammalian and microbial toxicity [29]. The high hydrophobicity provided by two tryptophan molecules in the tetrapeptide motif, together with the gradual increase in hydrophobicity by terminal acylation, is likely to ensure that membrane interactions are due to the molecule being highly 
hydrophobic rather than specific interaction with the anionic bacterial membranes. This is demonstrated by the large degree of activity expressed against zwitterionic mammalian cells. Attempts have been made to balance both salt resistance and membrane selectivity by variation of peptide hydrophobicity, 
charge, amphipathicity and degree of α-helicity [30], with some naturally occurring peptides such as the tachyplesins and the polyphemusins displaying salt-insensitive antimicrobial activities [31]. 
There is much debate as to the benefit of switching L-enantiomeric amino acid residues with their D-counterparts. Several studies presented in the literature show that the use of D-enantiomers of amino acid residues has no effect on improving haemolytic properties of antimicrobial peptides that share the same primary sequence [32]. In other studies the incorporation of D-amino acids into non-cell selective lytic peptides decreased their activity against eukaryotic cells. This was due to loss of 
the α-helical structure, whilst preserving their antibacterial properties via a carpet-like detergent mechanism as opposed to the formation of transmembrane (toroidal) pores [33] The main advantage of using more expensive D-enantiomers is to bestow proteolytic stability to antimicrobial peptides, which is alternatively provided to the tetrapeptide motif, by the use of the unnatural amino acid ornithine [34]. Hydrophobicity has a 
stronger influence in terms of cell toxicity. When this exceeds a threshold level, selectivity between prokaryotic and eukaryotic cells is lost, demonstrated by an increase in cytotoxicity [35]. Despite cytotoxicity against mammalian cells being demonstrated, no (or low) activity was demonstrated at the respective MICs of the compounds tested [1,2]. This selectivity for different membranes may potentially be harnessed in alternative areas of medicine. For example, some cationic peptides, such as 
LL-37 [36], have been demonstrated to possess potent activity against mammalian tumour cells that possess a higher negative membrane potential than non-cancer cells due to a higher 
density of anionic molecules such as O-glycosylated mucins (rich in negatively charged saccharides comprised of sialic acids and sulphates), sialilated gangliosides [37], phosphatidylserine [38,39] and heparin sulphates [40]. The majority of clinical trials completed or taking place involve the use of antimicrobial peptides in topical therapy. Lipopeptides such as polymyxin B are already utilised in skin creams, and, therefore, the potential therapeutic use of the most antimicrobially potent compound C12-OOWW-NH2 is still therapeutically viable. More advanced forms of topical treatment would include the use of these cationic compounds as aerosol therapy for the treatment of lung infections such as 
Pseudomonas aeruginosa colonisation in cystic fibrosis patients. This is especially true as the use of the polycationic lipopeptide, colistin, and the polycationic trisaccharides, tobramycin and gentamicin, have been successfully established [41,42]. However, owing to its increased action against Gram-positive bacteria, the 
release of these compounds from a polymeric/metallic/ceramic 
biomaterial in the prevention of biofilm- related device infection, where staphylococcal infection is particularly widespread, may prove more successful [43]. Despite the results obtained from the cytotoxicity studies outlined further in vivo, work involving 
human and/or animal studies would be required to correlate the true antimicrobial and toxic potential of such peptides clinically. 
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